1. 1. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA Cancer J Clin 1995;45:8-30. [PubMed]
2. Andrén O, Fall K, Franzén L, et al. How well does the Gleason score predict prostate cancer death? A 20-year follow-up of a population based cohort in Sweden. J Urol 2006;175:1337-40. [PubMed]
3. Landis SH, Murray T, Bolden S, et al. Cancer statistics 1998. CA cancer J Clin 1998;48:6-29. [PubMed]
4. Gleason DF, Mellinger GT. Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol.1974;111:58–64. [PubMed]
5. Xia T, Dong J, Zhang J. Gleason scores of prostate needle biopsy specimens and of radical prostatectomy specimens, a comparative study. Zhonghua Yi Xue Za Zhi. 2002;82:1604–5. [PubMed]
6. Emiliozzi P, Maymone S, Paterno A, Scarpone P, Amini M, Proietti G, et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J Urol. 2004;172:2224–6. [PubMed]
7. King CR, Patel DA, Terris MK. Prostate biopsy volume indices do not predict for significant Gleason upgrading. Am J Clin Oncol. 2005;28:125–9. [PubMed]
8. Sved PD, Gomez P, Manoharan M, Kim SS, Soloway MS. Limitations of biopsy Gleason grade: Implications for counselling patients with biopsy Gleason score 6 prostate cancer. J Urol. 2004;172:98–102.[PubMed]
9. Epstein JI, Sanderson H, Carter HB, Scharfstein DO. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology. 2005;66:356–60. [PubMed]
10. King CR, McNeal JE, Gill H, Presti JC Jr. Extended prostate biopsy scheme improves reliability of Gleason grading: Implications for radiotherapy patients. Int J Radiat Oncol Biol Phys. 2004;2:386–91.[PubMed]
11. Ghani KR, Grigor K, Tulloch DN, Bollina PR, McNeill SA. Trends in reporting Gleason score 1991 to 2001: Changes in the pathologist's practice. Eur Urol. 2005;47:196–201. [PubMed]
12. King CR. Patterns of prostate cancer biopsy grading trends and clinical implications. Int J Cancer 2000;90:305-11. [PubMed]
13. Bostwick DG. Gleason grading of prostate needle biopsies correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 1994;18:796-803. [PubMed]
14. Steinberg DM, Sauvegeot BS, Piantadosi S, et al. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 1997;21:566-76.[PubMed]
15. Pinthus JH, Witkos M, Fleshner NE, Sweet J, Evans A, Jewett MA, et al. Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: Implication on outcome. J Urol. 2006;176:979–84. [PubMed]
16. Buyyounouski M, Horwitz E, Hanlon A, et al. Positive prostate biopsy laterality and implications for staging. Urology 2003;62:298-303. [PubMed]
17. Gregori A, Vieweg J, Dahm P, et al. Comparison of ultrasound-guided biopsies and prostatectomy specimens predictive accuracy of Gleason score and tumor site. Urol Int 2001; 66:66-71. [PubMed]
18. Stricker HJ, Ruddock LJ, Wan J, et al. Detection of non-palpable prostate cancer a mathematical and laboratory model. Br J Urol 1993;71:43-6. [PubMed]
19. Bostwick D, Meiers I. Prostate biopsy and optimization of cancer yield. Eur Urol 2006; 49:415-7.[PubMed]
20. Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer. Can Urol Assoc J. 2007 Sep; 1(3): 264–266. [PubMed]